These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37024846)
1. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study. Huang Q; Li F; Ji M; Lin L; Hu C BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846 [TBL] [Abstract][Full Text] [Related]
2. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status. Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624 [TBL] [Abstract][Full Text] [Related]
3. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma. Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151 [TBL] [Abstract][Full Text] [Related]
4. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M Eur Urol; 2024 Aug; 86(2):114-127. PubMed ID: 38670879 [TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population. Wang Z; Xia RH; Ye DX; Li J PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915 [TBL] [Abstract][Full Text] [Related]
6. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy. Kashofer K; Regauer S Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674 [TBL] [Abstract][Full Text] [Related]
7. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary. Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma. Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038 [TBL] [Abstract][Full Text] [Related]
9. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection. Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655 [TBL] [Abstract][Full Text] [Related]
12. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Maruyama H; Yasui T; Ishikawa-Fujiwara T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Hongyo T; Inohara H Cancer Sci; 2014 Apr; 105(4):409-17. PubMed ID: 24521534 [TBL] [Abstract][Full Text] [Related]
14. Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains. Ordi O; Saco A; Peñuelas N; Blanco-Irazuegui O; Pino MD; Carreras-Dieguez N; Marimon L; Rodrigo-Calvo MT; Morató A; Sisuashvili L; Bustamante M; Cruells A; Darecka K; Vega N; Alós S; Trias I; Fusté P; Parra G; Gut M; Munmany M; Torné A; Jares P; Rakislova N Mod Pathol; 2024 Oct; 37(10):100574. PubMed ID: 39089654 [TBL] [Abstract][Full Text] [Related]
15. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group. Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182 [TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status. Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857 [TBL] [Abstract][Full Text] [Related]
17. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303 [TBL] [Abstract][Full Text] [Related]
18. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up]. Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570 [TBL] [Abstract][Full Text] [Related]
19. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma. Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]